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Abstract
Background: Herein we present our experience with laparoscopic common bile duct exploration (LCBDE) in
managing common bile duct stones.
Methods: Data of 129 consecutive patients who underwent laparoscopic cholecystectomy (LC) and LCBDE done at
our institutes from April 2011 through June 2016 were prospectively recorded and retrospectively reviewed.
Results: Since 2011, 3012 laparoscopic cholecystectomy were performed at our institutes, intraoperative cholangiogram
(IOC) was done in 295 (9.8%) patients which detected choledocholithiasis in 129 (4.3%) of them. LCBDE was successful to
clear the common bile duct (CBD) in 123/129 (95.4%). Six patients underwent postoperative endoscopic retrograde
cholangiopancreatography (ERCP) because of incomplete CBD clearance (4 cases), symptomatic stenosed papilla (2 cases).
LCBDE was performed in 103 patients via trans-cystic approach and choledochotomy one in 26 patients. In the
choledochotomy group, seven patients had primary closure of the CBD, CBD was closed over T-tube in nine patients
whereas the remaining 10 patients the CBD was closed over antegrade inserted stent. The median time of hospital stay
was 4 (range; 1–15) days. No patients showed retained CBD stones with mean follow up was 9 ± 3.4 months.
Conclusion: LCBDE is a safe and cost effective option for CBD stones in short-term outcome and can be performed
provided proper laparoscopic expertise and facilities are available.
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Background
Approximately 9–16% of patients who have gall bladder
stone harbor common bile duct stones [1, 2]. Open
cholecystectomy with CBD exploration and clearance
was the standard treatment of CBD stone associated
with gall bladder stone [3, 4]. With increasing experience
in laparoscopy and as laparoscopic cholecystectomy
(LC) became the standard treatment for gall bladder
stone, management of CBD stones strategy has been
changed and endoscopic retrograde cholangiopancreato-
graphy (ERCP) got the upper hand in this field preceded
with or followed by LC (two stage procedure) [5]. It has
been reported that endoscopic sphinctrotomy has up to
15% morbidity rates and 1% mortality rates and it also
increase the cost cause of two stage procedure and it
may cause recurrent ductal stones and stenosis of the
papilla with cholangitis. Accordingly and in addition to
the surge in laparoscopic experience, LCBDE becomes a
potential option for managing CBD simultaneously with
LC (one stage procedure) [6].
We aimed in this retrospective study to evaluate our
initial experience in using LC and LCBDE as a single
stage procedure for management of CBD stones with
gall bladder in situ.
Methods
From April 2011 to June 2016, we performed 3012 laparo-
scopic cholecystectomy at our institutes (Theodore Bilharz
Research Institute, Egypt, Mansura University Hospital-
Egypt, Hafer Albatin Central Hospital, KSA, University of
Jeddah-KSA, Al-Jahra hospital, Kuwait). Two hundred
ninety-five patients had the indications to undergo intraop-
erative cholangiogram which documented presence of CBD
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stones in 129 patients. These 129 patients’ data were pro-
spectively collected and enrolled in this study.
Patients’ selection
Patients with history of classic biliary pain and jaundice
had underwent routine preoperative preparation including
complete blood count (CBC), coagulation profile,
kidney functions, liver function tests (LFTs), abdo-
minal ultrasonography and routine pre-anaesthetic
evaluation to determine ASA status. Magnetic reso-
nance cholangiopancreatectomy (MRCP) was done in
31 patients. Intraoperative cholangiogram (IOC) was
performed for patients with gall bladder stones who
had one or more of the following; classic biliary pain,
history of biliary pancreatitis, unexplained LFTs ab-
normalities, and radiologic evidence of dilated biliary
tree or CBD stones. LCBDE was done if there were
abnormal intraoperative cholangiogram findings (one
or more) such as filling defect, wide diameter biliary
tree or abnormal passage of contrast into the duo-
denum. This study was approved by institutional re-
search board (IRB). An informed consent was
obtained from all patients after been provided with
information about their disease, the current updated
treatment options and possibility of conversion to
conventional one, T-tube insertion and postoperative
ERCP if indicated.
On June 2016, the 129 patients’ data sheets were retro-
spectively reviewed in respect to their preoperative, opera-
tive notes and postoperative data. Preoperative data
include; age, gender, body mass index (BMI), ASA status,
liver function tests (LFTs), ultrasonography and magnetic
resonance cholangiopancreatectomy (MRCP) if done.
Operative data include; operative time, transcystic or
transcholedochal approach. Postoperatively, the hospital
stay, wound infection, LFTs abnormalities or pancreatitis
were all looked for as well as bile leak, cholangitis,
bleeding and follow up data for stone recurrence.
Operative technique
All patients received prophylactic antibiotic and DVT
prophylaxis according to the local policy. The procedure
was done in supine position with adjustable operative bed
to allow fluoroscopic C- arm for imaging the patient’s
right upper quadrant. The procedure was carried out
using a 4-trocars laparoscopic cholecystectomy technique.
After dissecting the Calot’s triangle, the cystic artery was
clipped and transected. A clip was applied on the gall
bladder side of the cystic duct to prevent stone slippage
either into CBD or the operative field while the cranial
side was left connected with the CBD. A small diameter
catheter was introduced through a small nick in the cystic
duct down to the CBD to flush it and to do intraoperative
cholangiogram to look for filling defect, its size, site, and
number and free passage of contrast into the duodenum
or any anatomical variation if any.
Transcystic clearance (103 patients)
After dilating the cystic duct and on a guide wire, the
CBD stones were extracted by flushing or with help of
Dormia basket or balloon catheter to pull stones into
the intra-abdominal cavity to be retrieved. A complete
stone clearance was confirmed by completion cholangio-
gram or choledechoscope. The CBD side of the cystic
duct was clipped and the gall bladder was removed in
the usual manner (Figs. 1 and 2).
Choledochotomy approach (26 patients)
This approach was used either after failed trial of cannu-
lation of cystic duct or failed stone extraction through
cystic duct, in three patients, we employed it without
trying the trans-cystic technique because they were post
failed ERCP due to big impacted stones. IOC was done
through CBD puncture with lumber needle which
showed CBD stones. In these cases we converted to
choledochotomy in which the CBD was exposed and a
vertical ductotomy was done on the anterior surface of
the duct below the junction between cystic duct and
CBD (Fig. 3). The techniques for stone clearance are
Fig. 1 intraoperative cholangiogram showing a filling defect that
prevents passage of contrast into the duodenum
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identical to the trans-cystic approach. Through the
choledochoscope, flushing with saline was done under
pressure to facilitate clearance of small stones. Dormia
basket and/or balloon catheter can be also used to pull
stones to the abdominal cavity then to be retrieved
outside (Fig. 4). The choledochotomy was closed over a
T-tube in nine cases and over an antegrade stent in 10
cases; the stent was inserted through the site of cholo-
dotomy under guidance of fluoroscopy for removal by
ERCP later. Primary closure of the CBD was done in the
remaining seven patients with absorbable suture. Exter-
nal tube drains were used only when we perform chole-
dochotomy technique and not used in trans-cystic
technique.
Statistics
All data were prospectively collected in designed sheets
and were reviewed retrospectively for statistical
purposes. Continuous variables were compared using a
Student t-test or Mann-Whitney test, as appropriate.
Chi-square test was used for comparing categorical vari-
ables. P < 0.05 was considered statistically significant. Data
are expressed as mean (SD). Statistical analysis was per-
formed using a commercially available software package
(SPSS version 11.5 for Windows; SPSS Inc, Chicago, IL).
Results
From April 2011 to June 2016, we performed 3012 laparo-
scopic cholecystectomy at our institutes. 295 (9.8%) out
3012patients have undergone intraoperative cholangio-
gram and 129 (4.3%) were diagnosed to have choledocho-
lithiasis. Male to female ratio was 43/86, with mean age of
37 ± 8 years (range 27 to 57 years) (Table 1). Transcystic
exploration was done in 103 patients. Transcholedochal
route was performed in 26 patients, 13 patients had too
big CBD stones to be extracted through cystic duct, and
11 had failed cannulation of the cystic duct while in three
patients choledochotomy was employed from the start
due to post failed ERCP clearance of big impacted stones.
In transcholedochal LCBDE group (26 patients), primary
closure of CBD was done in seven patients, nine patients
had CBD closed over T-tube whereas 10 patients closed
over stent. All patients survived the operation with 0%
conversion rate to open surgery. Six patients underwent
postoperative ERCP because of incomplete CBD clearance
(4 cases), symptomatic stenosed papilla (2 cases). The dur-
ation of the operation was 126 min (range, 102–140 min)
in both trans-cystic and choledochotomy techniques.
Intraoperative blood loss was minimal (less than 10 ml)
with no intraoperative complications (Table 2).
During patients’ stay, patients’ assessment was done
clinically and by laboratory evaluation. Transient colic pain
occurred in two patients with elevated liver enzymes. One
was managed conservatively and the other patient had sus-
tained severe biliary colic for 2 days after her operation and
sent for higher hospital to do ERCP which revealed very
tight papilla without any CBD stones, sphincterotomy
cured the problem. A transient increase in the LFTs (AST
& ALT) was observed in three patients, it went back to
Fig. 3 Choledocotomy technique and extraction of big CBD stone
Fig. 2 Trans-cystic stone extraction by Dormia basket
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normal on postoperative day 3 with no treatment (Table 3).
All patients had an uneventful postoperative period and
were discharged home with median hospital stay of 4
(range;1–15 days). In trans-cystic approach group, the pa-
tients were discharged home on day 3–4 postoperatively
once we were completely assured that the operation. If T-
tube was inserted, a post-operative cholangiogram was
done after 7–10 days and if free, the tube was clamped and
left in place for total 14 days. No haemobilia, abdominal
bleeding, or pancreatitis occurred in our series.
Upon discharge, patients were instructed for first fol-
low up after 1 week to have stitches and T-tube removed
provided cholangiogram was unremarkable. Schedule of
follow up was then given for patients every 6 months
during the first year and annually thereafter. Clinical
evaluations and liver function tests were done every visit
and additional imaging studies were requested if needed.
In one patient, T-tube was removed on day 11 post-
operatively, but she developed bile leak after removal
which necessitated 2 extra days admission, had been
treated conservatively and discharged home in good
condition. Another patient, female 37 years old, in
choledochotomy group with T-tube closure, the catheter
6 Fr failed to pass through the papilla. The average T-
tube drainage was around 400 ml bile and her posto-
perative cholangiogram showed tight papilla with no
residual stones, she had been sent to another hospital to
have ERCP which revealed no residual stones and
sphincterotomy was sufficient. Her T-tube was clamped
for one more week and removed after normal cholan-
giogram. Three patients developed wound infection
Fig. 4 Intraoperative trans-cystic Choledocoscope
Table 1 Patients’ characteristics and preoperative parameters
Variable Patients N = 129
Age 37 ± 8 years (range 27 to 57 years)
Gender (female/male) 93/36
Weight 69 ± 13 (59–126 kg)
Height 157 ± 15 (149–178 cm)
BMI 29 ± 6 (23–46)
ASA
ASA I 76 (59%)
ASA II 47 (36.4%)
ASA III 6 (4.6%)
Hx of biliary pain 59 (45.7%)
Hx of jaundice 9 (7%)
Hx of pancreatitis 13 (10%)
Mean bilirubin 1.003 ± 0.003 (0.3–3.2 mg)
Mean ALP 175 ± 19 (71–396 U)
Mean ALT 209 ± 32 (31–702 U)
Mean ALT 195 ± 29 (29–560 U)
Mean CBD diameter 7.3 ± 1.7 (4–19 mm)
ALP alkaline phosphatase, ALT Alanine transaminase, AST Aspartate
transaminase, hx history, ASA American Society of Anesthesiologists
Table 2 Operative outcomes









Operative time 126 (range, 102–140 min)
LC 39 ± 13 (25–59 min)
Trans-cystic 40 ± 16 (37–63 min)
Trans-choledochotomy 59 ± 19 (47–109 min)
Mean No. of CBD stones 2.4 ± 1.6 (1–7)
Mean size of stones 4.2 ± 1.3 (3–15 mm)
Mean blood loss 10 ± 3.6 (5–50 ml)
Blood transfusion 0
IOC intraoperative cholangiogram, CBD common bile duct, LCBDE laparoscopic
CBD exploration, LC laparoscopic cholecystectomy
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(umbilical port) that was treated conservatively. There
were no mortalities and all procedures had been com-
pleted laparoscopically with no conversion to open.
The mean follow up was 9 ± 3.4 months (2–39 months).
No patients showed retained CBD stones by clinical, la-
boratory and imaging studies. We used the Dindo-Clavien
classification to stratify the severity of operative and
postoperative complications [7].
Discussion
If 9–16% of patients who have cholelithiasis harbour con-
comitant CBD choledocholithiasis, so it is a considerable
problem that requires a proper strategy to solve. Options
are many, starting from open cholecystectomy with open
CBD exploration to laparoscopic cholecystectomy with
pre- or post-operative ERCP then laparoscopic cholecyst-
ectomy with LCBDE. The introduction of laparoscopic
CBD exploration has made it possible to avoid the
drawbacks of both two-stages procedure (laparoscopic
cholecystectomy plus pre- or post-operative ERCP) and
also the drawbacks of the open CBD exploration [8, 9].
LCBD were not commonly used by surgeons till very late
after introduction of laparoscopic cholecystectomy. The
reasons for this delay are because it needs instrumental
difficulties as well as the rely of most of surgeons on the
alternative interventional methods especially ERCP be-
cause LCBDE is technically demanding and needs high
level of experience [10, 11].
In this study, we present our preliminary experience of
LCBDE in our institutes with success rate of 95.4% (123/
129) which are comparable to the results of ERCP &
open CBD exploration with less morbidity and mortality
and hopefully the success rate will increase with increa-
sing experience [12, 13].
The trans-cystic approach is technically easier, feasible,
and less invasive with better patients’ satisfaction.
Surgeons usually try it first but it has its limitations and
indications e.g. dilated cystic duct, small stones (preferably
single stone) and there should be no stent in the CBD [3,
11–13]. We performed this approach in 103/129 (79.8%)
patientswith success rate of 98/103 (95%) which is almost
comparable to others. Whenever this approach is difficult
or impossible, we converted to trans-choledochal one.
The choledochotomy approach is technically demanding
and needs advanced laparoscopic experience [6, 14, 15].
29/129 (20.2%) patients have been undergone LCBDE
through transcholedochal route with 28/29 (96.6%) suc-
cess rate. We performed this choledochotomy approach
after failed trials of trans-cystic route either due to failed
cannulation or failed stone extraction through cystic duct.
Choledochotomy technique was our first choice without
trying the trans-cystic technique in three patients with
failed ERCP due to impacted big stone in the CBD.
We routinely used intraoperative cholangiogram before
stone extraction for confirmation the presence of stones
and after to make sure of complete clearance of the CBD.
Choledocoscope is a very helpful tool in CBD exploration,
in both direct visualization of the intraluminal stones and
also in removing them by the aid of Dormia basket or
Fogarty’s vascular catheter [8, 16–18]. We used the chole-
docoscope in most of our cases to confirm the complete
clearance of the CBD and to inject saline for washout of
stone fragments and debris.
In our study we closed the choledocotomy over T-tube in
10/26 cases (38.5%). Closure over T-tube provides biliary
decompression especially when there was concern about
retained fragments or tiny stones, it enables us for imaging
the biliary system postoperatively and it provides an access
through which any retained stones can be removed. T-tube
has its disadvantages, it might make a way for bacteraemia,
accidental premature dislodgment, obstruction and it might
be associated with bile leak and peritonitis at its removal.
Closure over stent was used in 9/26 cases (34.6%) which
provides safe closure of choledochotomy as it provides
biliary decompression same as T-tube does without its dis-
advantages, however, it needs follow up ERCP to remove it
later. Finally, primary closure without stent was used in 7/
Table 3 Postoperative outcomes
Variable Patients N = 129
Return to oral intake 6 ± 2.3 (4–19 h)
Return to activity 17 ± 5.3 (6–29 h)
Hospital stay 4 (range;1–15 days)
-Trans-cystic 2 (range;1–3 days)
-Trans-choledochectomy 6 (range; 4–15 days)
Mean postop. bilirubin 0.6 ± 0.03 (0.4–3.2 mg)
Mean post-op. ALP 129 ± 18 (74–293 U)
Mean post-op. ALT 113 ± 11 (23–174 U)
Mean post-op. AST 159 ± 19 (19–163 U)
Mean T-tube cholangiogram 5.2 ± 3 (4–8 days)





-Accidental T-tube displacement (II) 0
-Transient liver enzymes elevation (I) 3 (2.3%)
-Wound infection (II) 3 (2.3%)
-Choleperitoneum (II) 1 (0.76%)
-Pneumonia (II) 0
-Biliary colic (II) 2 (1.5%)
-Abdominal bleeding (II) 0
ALP alkaline phosphatase, ALT Alanine transaminase, AST Aspartate
transaminase, * Dindo-Clavien classification
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26 cases (26.9%) and wehave no bile leakage in our cases
and we have no intra-abdominal collections as well.
However, the length of stay for the laparoscopic chole-
cystectomy is generally short (from 1 to 3 days), it is
longer for laparoscopic CBD exploration 1–7 days in
most of studies [12, 18–20]. In our study, the length of
stay depended upon the technique employed; it was 1–3
days in trans-cystic group and longer (4–15 days) in
choledocotomy one especially when we used T-tube to
close the choledocotomy.
In most of studies the mortality of laparoscopic CBD
exploration is 0 to 1% in the hands of experienced biliary
surgeons. This rate is similar to the incidence found in
open CBD exploration [21–25]. In our study, we have
no reported mortality cases, which may be attributed to
improved preoperative preparation, improved anaesthe-
sia and selection of cases.
Our study has some limitations, it is a retrospective
study and showed a wide heterogeneity among the sur-
geons’ experience in performing this LCBDE. The sam-
ple size of patients enrolled in this study is relatively
small. This study represents our initial experience in
preforming LCBDE, this represents a limitation per say.
We recommend for another study to be done in a pro-
spective way and to enrol a much larger sample size.
Laparoendoscopic rendezvous is a promising alternative
and has many pros; it provides selective cannulation of
CBD and avoids both inadvertent cannulation of pan-
creatic duct with subsequent accidental injection of the
contrast under pressure into the pancreatic duct [26]. We
had six patients underwent postoperative ERCP, 4 because
of incomplete CBD and two cases due to sympto-
matic stenosis of the papilla. Some hospitals at which
this study was conducted are lacking for ERCP ser-
vices. ERCP is crucial because it is the cornerstone
for LCBDE, it provides an alternative optionfor pa-
tients with CBD stones synchronous with gall bladder
stones and relieved stenosis when present as shown
in our study. Therefore a limitation in our study is
the lack of access of ERCP for the six patients due to
unavailability in hospitals (two patients) and gastroen-
terologists (four patients). However, if available, Lapa-
roendoscopic rendezvous would have been an
excellent intervention for these six patients.
Conclusion
Laparoscopic CBD exploration is an effective single stage
procedure for the treatment of GB and CBD stone in
one session making use of the benefits of minimally
invasive approach and avoiding the drawbacks of ERCP
as well as open CBD approach. LCBDE can be per-
formed after proper training and adequate equipment
and laparoscopic facilities.
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